Elm Street Ventures β Full Portfolio
4 tracked investments Β· listed companies and verified rows first
Allyx Therapeutics is a clinical-stage biopharmaceutical company developing therapies to preserve and protect synapses in people with neurodegenerative diseases.
BiotechDigital HealthHealthtechNew Haven, US
Paul Fonteyne(Co-Founder)inStephen Strittmatter(Scientific Founder)inStephen Bloch(CEO & Co-Founder)inTimothy Siegert(COO, Co-Founder)inTim Siegert, PhD(COO & Co-Founder)Jennifer Gabler(Executive Officer)in
Co-investorsSpring Mountain CapitalConnecticut InnovationsWHIN
Elm Street Ventures is a seed and early-stage venture capital fund that invests in startups with a Yale University connection, typically commercializing research licensed from Yale, as well as companies in the greater New Haven area.
BiotechClimate TechDeep TechNew Haven, US
Co-investorsConnecticut InnovationsOmidyar Network
Enrich HK supports migrant domestic workers in Hong Kong through financial education, wellness programs, and community initiatives.
FintechHR TechImpact & Social GoodWellness & FitnessHong Kong, HK
Suzanne Gendron(Executive Director)inTynna Mendoza(Interim Executive Director)in
Co-investorsAVPN
SeeClickFix 311 CRM by CivicPlus is a 311 platform that lets residents report local issues, request repairs, and send feedback or questions to their local government.
GovTechSaaSNew Haven, US
Charles Kampmann Lasater(Executive Officer, Director)Ben Berkowitz(Executive Officer, Director)Miles Lasater(Director)in
BoardMark Jacobsen(Director)
Co-investorsLaunchCapitalConnecticut Innovations
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.